Administration faces opposition to changes in Medicare prescription drug program

Kaiser Health News / USA Today, March 3, 2014
Medicare's prescription drug program was controversial when it arrived, but a decade later it is widely considered to be a Washington success story. Now, though, the Obama administration is proposing a series of significant changes to fix what critics say isn't broken. Administration officials say they want to help beneficiaries make good choices and save taxpayers money. But some patient groups, pharmaceutical manufacturers and lawmakers in both parties are pushing back against various elements. The regulation would affect several aspects of the Medicare drug program, also known as Part D, ranging from new limits on the number of plans insurers could offer consumers to new rules about what drugs those plans must cover.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.